Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion type Assertion NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_head.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_provenance.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion evidence source_evidence_literature NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_provenance.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion SIO_000772 19800578 NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_provenance.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion wasDerivedFrom befree-20150227 NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_provenance.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion wasGeneratedBy ECO_0000203 NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_provenance.